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Introduction 
Depression is a multifactorial, chronic, and life-threa-
tening disease with globally high prevalence. Currently, 
29% of the world population suffer from depression, 
considered to be one of the 10 leading causes of death 
(Menken et al., 2000; Grundmann et al., 2010; Singer et 
al., 2011; Cassani et al., 2015) According to the World 
Health Organization, depression will be the second 
leading disease in the developed countries in 2020 
(Abbasi et al., 2013).  
Depression affects not only the patients but also their 
friends and families. Social withdrawal, lack of motiva-
tion, sexual dysfunction, sleep disorders (in 75% of the 
patients), nightmares, depressed mood, and anhedonia 
are the main symptoms of depression (Abbasi et al., 
2013). Fifteen percent to 25% of patients with depre-
ssion have suicidal thoughts and sadism (Harati et al., 
2014). 
Different factors including biological, inherited, and 
psychosocial contribute to the development of depre-
ssion. Recently, internal stressors such as variations in 
serum levels of cholesterol, triglyceride, sugar, and 
coagulation factors have been reported to be involved 
in the development of depression (Babri et al., 2012). 
Currently, certain drugs including lithium salts, stimu-
lants, tricyclic antidepressants, serotonin inhibitors, and 
monoamine oxidase inhibitors are used to treat 
depression (Kamalipour et al., 2008). 
These drugs may work some weeks to some months 
after use. Depression symptoms and signs are fully 
treated in only 1/3 of people and the recurrence risk 
persists. Besides that, they can cause several adverse 
effects such as sleepiness, dry mouth, constipation, and 
impotence.  
Currently, researchers are seeking out more specific 
drugs with higher safety and lower cost. Medicinal 
plants have attracted the attention of the researchers 
working in this field because these plants have long 
been used to treat different diseases, including psychia-
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Abstract
Depression is a life-threatening, debilitating, and common disease affecting 
different segments of community. Chemical and synthetic drugs available to 
treat this disease cause many adverse effects and may lead to complete 
recovery in only 50% of patients. At the same time, medicinal plants have 
been reported to exert optimal pharmacological effects in treating depression 
in different models. In this review, the relevant articles indexed in the reliable 
databases PubMed, PubMed central, Scopus and Web of Science were review-
ed. The review indicated that most medicinal plants exerted antidepressant 
effects through synaptic regulation of serotonin, noradrenaline, and 
dopamine, regulating activity of hypothalamic-pituitary-adrenal axis, reinfor-
cing anti-oxidant defense system, and decreasing inflammatory mediators. 
The medicinal plants and their active compounds can relieve depression 
through different pathways and hence are considered a new source to 
produce antidepressants.
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 tric disorders, and cause fewer adverse effects than 
synthetic and chemical drugs (Richelson, 1994).  
The aim of this article is to review the findings of the 
studies on antidepressant effects and mechanism of 
action of medicinal plants and the biological com-
pounds of these plants responsible for the antidepre-
ssant action. 
 
Biomarkers to study depression 
Monoamine neurotransmitters such as serotonin (5-
HT), noradrenaline and dopamine play a significant 
part in mediating depressive behaviors. Depression 
symptoms develop mainly due to declined activity of 
these neurotransmitters. Monoamine oxidase (MAOA) 
is a key enzyme that is dependent on neuro-
transmitters metabolism. MAOA activity rate has been 
suggested to be one of the susceptibility indices of 
psychological trauma (Pan et al., 2005). 
The function of hypothalamic-pituitary-adrenal (HPA) 
axis has been demonstrated to become defective in 
patients with depression. Corticotropin-releasing factor 
(CRF) is the main physiological regulator of HPA axis 
and contributes fundamentally to mediating behavioral, 
neuroendocrine, and autonomic responses to environ-
mental stimuli. Increased amount of CRF and excessive 
activity of HPA axis are considered depression indices 
(Barden et al., 1995; Pan et al., 2007). 
Excessive release of glucocorticoid hormones, such as 
corticosterone in mice and cortisol in humans, that are 
produced in response to stressful conditions, is also an 
indicator of HPA axis excessive activity and develop-
ment of depression (Xu et al., 2008). Fluoxetine has been 
demonstrated to be able to decrease the escalated 
amounts of serum corticosterone in mice with depre-
ssion (Song et al., 2006). The amounts of corticotropin 
releasing hormone (CRH), cortisol, and adrenocortico-
tropin hormone (ACTH) have been reported to be 
higher in people with depression than other people 
(Plotsky et al., 1998). 
Adenylyl cyclase is a drug that regulates the physio-
logical effects of drugs and hormones through produ-
cing cAMP. cAMP is a secondary messenger involved 
in depressant and antidepressant processes. Adenylyl 
cyclase activity has been demonstrated to be associated 
with major depressive disorder. First, the brain 
(Cowburn et al., 1994) but then the platelets of suicide-
attempting people with previous depression were used 
to study adenylyl cyclase activity in these people. 
Adenylyl cyclase has been demonstrated to be less 
active in people with depression than other people 
(Menninger and Tabakoff, 1997). Therefore, adenylyl 
cyclase activity can be considered to be the biological 
index of depression (Li et al., 1999). Adenylyl cyclase 
activity is controlled by serotonergic system receptors; 
serotonergic system, HPA axis, and adenylyl cyclase-
cAMP pathway have been demonstrated to interact 
with each other due to chronic stress in rats with 
depression (Xu et al., 2008). 
Oxidative stress, a type of imbalance between the 
production of reactive oxygen species and anti-oxidant 
defense system, is one of the factors involved in the 
pathogenesis of depression. Different degrees of oxide-
tive damage and a decline in anti-oxidant enzymes 
have been reported in people with depression (Pandya 
et al., 2013). Use of anti-oxidant compounds such as n-
acetyl cysteine causes decrease in depression symptoms 
in people with depression. Besides that, antidepressants 
are able to decrease some of the oxidative stress indices 
and cause an increase in certain internal anti-oxidants 
(Maes et al., 2011). 
Evidence indicates that certain inflammatory mediators 
such as tumor necrosis factor (TNF)-ǂ and interleukin 
(IL)-1ǃ are involved in the development of depression 
in both affected people and animal models (Liu et al., 
2015). In a study, administration with IL-6, IL-1ǃ, TNF-
ǂ, and lipopolysaccharides caused induction of depre-
ssion- and anxiety-associated behaviors (Sukoff Rizzo et 
al., 2012). 
As well, depression symptoms are seen in people with 
hepatitis C or cancer who are under immunotherapy 
with IL-2 and TNF-ɣ. This confirms an association 
between inflammation and depression (Dutcher et al., 
2000). Certain antidepressants such as fluoxetine and 
paroxetine are able to reduce inflammatory cytokines in 
the brain and blood (Hwang et al., 2008). 
Disturbed metabolism of energy, amino acids, intestinal 
microflora, and amino acid neurotransmitters are 
associated with depression, which can be inferred from 
significant variations in their biomarkers (Xing et al., 
2015). Creatinine and succinic acid play role in energy 
transport and creeps cycle whose inefficiency due to 
depression leads to disturbed energy metabolism and 
feeling tired, a main symptom of depression. Phenyl-
alanine is an essential amino acid that acts as a 
precursor of tyrosine. Certain monoamine neurotrans-
mitters including serotonin, norepinephrine, and 
epinephrine are derived from phenylalanine. 
Tryptophan is an essential amino acid and the 
precursor of serotonin. Therefore, the variations in 
tyrosine, tryptophan, and phenylalanine that represent 
disturbed metabolism of amino acids are associated 
with depression. 
Hippuric acid is one of the phenylalanine metabolites 
that is metabolized by intestinal microflora. 3-Indole-
acetic acid is produced by intestinal microflora-induced 
changes in tryptophan. Depression-induced variations 
in these biomarkers may represent an association 
between depression and intestinal microflora 
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 metabolism (Ladep et al., 2006). Glutamic acid and 
amino butyric acid (GABA) serve as stimulatory and 
inhibitory neurotrans-mitters in mammalian brain and 
contribute significantly to mediating anxiety- and 
depression-associated behaviors (Zheng et al., 2010). 
An experimental study demonstrated that the amounts 
of tryptophan, phenyl, tyrosine, creatinine, succinic 
acid, 3-indoleacetic acid, and hippuric acid were lower 
in mice with depression than control mice, and use of a 
traditional Chinese medicinal plant, Zhi-Zi-Hou-Po, 
caused the amounts of these factors to reach normal 
levels. This medicinal plant also decreased the levels of 
glutamic acid and amino butyric acid to baseline levels 
(Xing et al., 2015). 
Medicinal plants have been used to treat depression for 
thousands of years. Some of them include poppy 
(opium), deadly nightshade (Atropa belladonna), 
Indian hemp (hashish), henbane (hyoscyamine), thorn 
apple (scopolamine), and St. John’s wort (hypericum 
oil). Opium poppy is widely cultivated and used by the 
Sumerians of the third millennium BC. Opium, the 
congealed latex from unripe poppy capsules, was also 
used in Minoan culture during the Bronze Age in the 
3rd and 2nd millennium BC. Atropa belladonna from the 
deadly nightshade and hashish from Indian hemp were 
used and cultivated as early as the third millennium BC 
in Egypt and Assyria. Hyoscyamine (a psychotropic 
alkaloids from henbane) and scopolamine (from thorn 
apple) are mentioned in the famous Ebers Papyrus 
(Egypt, 1500 BC) (Ban, 2001). 
 
Medicinal Plants 
Danggui-Shaoyao-San 
Danggui-Shaoyao-San is a traditional Chinese medici-
nal plant routinely used in Asian countries. This herb 
contains six plants, Radix Angelicae sinensis, Poria cocos, 
Rhizoma Alisma orientalis, Radix Paeonia lactiflora, and 
Rhizoma Ligusticum chuanxiong, and is routinely used to 
treat gynecological disorders such as painful menstrual 
periods and postmenopausal problems.  
Danggui-Shaoyao-San causes improvement of memory 
and learning impairment through preventing destruc-
tion of nerve cells and oxidative stress, decreasing and 
preventing accumulation of amyloid beta plaques, 
increasing synaptic plasticity, and reinforcing long-term 
potentiation (Hu et al., 2012). The analgesic effects of 
this plant-based combination have been demonstrated, 
as well (Li et al., 2014).  In a study, Danggui-Shaoyao-
San was found to exert therapeutic effects on chronic 
stress-induced depression. In addition, this remedy was 
effective in treating certain depression-associated 
symptoms such as weight loss, anorexia, investigative 
and locomotive activities, and insomnia (Zhou et al., 
2015). 
Chronic stress causes sleep disorders by affecting 
certain neurotransmitters such as dopamine, serotonin, 
and norepinephrine that exert regulatory effects on 
sleep-wake cycle. A study showed that Danggui-
Shaoyao-San caused an increase in monoamine neuro-
transmitters in the brain of elderly mice (Kou et al., 
2005). A study on the antidepressant mechanism of 
Danggui-Shaoyao-San demonstrated that this remedy 
caused adjustment of noradrenaline and dopamine 
levels that were already decreased due to chronic stress 
as well as a decrease in malondialdehyde (MDA), and 
increase in superoxide dismutase (Huang et al., 2012). 
The observed antidepressant effects of Danggui-
Shaoyao-San can be related to the main compounds 
identified in this plant including albiflorin,  paeonflorin, 
fluoric acid, ligustrazine, ligustilide and ateraacetylli-
noid. Fluoric acid is a phenolic compound and 
contributes to treating and preventing a variety of 
diseases and disorders. Its sodium salt has been 
approved by the China Food and Drug Administration 
to treat cerebrovascular and cardiovascular diseases 
(Zhou et al., 2015). 
Fruolic acid induces antidepressant effects through 
affecting serotonergic system (Zeni et al., 2012). Paeon-
florin, another main compound of Danggui-Shaoyao-
San, caused the release of serotonin and norepinephrine 
from synaptosome and hence induction of anti-stress 
actions (Qiu et al., 2013). 
Six medicinal materials were mixed in proportion and 
were macerated for 1 hour with eight volumes of dis-
tilled water and then decocted for 1.5 hours. Next, the 
cooled extract was filtered. The extraction procedure 
was repeated twice. The extracted fractions were pool-
ed and concentrated using a rotary evaporator (Huang 
et al., 2012). 
Epimedium brevicornum 
In traditional Chinese medicine, E. brevicornum is used 
to reinforce kidneys and enhance the body's forces. This 
plant has a wide-spectrum of biological and pharmaco-
logical actions and contributes to regulating cardio-
vascular system, circulation, and reproductive system. 
E. brevicornum can exert estrogenic effects and is used to 
treat menopause symptoms (Pan et al., 2005). A number 
of studies have confirmed the antidepressant effects of 
E. brevicornum extract (Lai, 2001; Zhong et al., 2005). E. 
brevicornum extract seems to induce antidepressant 
effect through suppressing MAOA and monoamine 
oxidase B (MAOB) and reducing serum MDA (Zhong et 
al., 2005). 
The flavonoids extracted from E. brevicornum increase 
certain neurotransmitters such as 5-HT and 5-HIAA, 
and gene expression of neurotransmitters receptors in 
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 the pituitary (Shen et al., 2004). The main compound of 
this plant, i.e. icarine (Figure 1), is a flavonoid 
compound and able to pass freely through the blood-
brain barrier and reduce brain inflammation and 
oxidative damage (Liu et al., 2015). Chronic stress 
caused physiological variations such as reduced sucrose 
preference and increased immobility (Liu et al., 2015).  
In addition, chronic stress increases oxidative stress 
markers and inflammatory mediators such as TNF-ǂ 
and IL-1ǃ and causes activation of nuclear factor κ 
messenger pathway and expression of nitric oxide syn-
thase mRNA. Treatment with 20-40 mg/kg icarine 
caused decrease in oxidative stress markers and infla-
mmatory mediators in the brain and significantly 
decreased depression symptoms in mice (Liu et al., 
2015). 
A study investigated the therapeutic effects of E. 
brevicornum-isolated icarine on chronic stress-induced 
depression. In this study, chronic stress was found to 
increase CRF and decrease serum triyedothyroine (T3), 
but caused no significant variations in ACTH and 
thyroxine (T4). Subsequent treatment with icarine 
improved depression symptoms and decreased already 
escalated levels of CRF in the brain and serum in mice. 
Antidepressant effects of icarine can be due to 
adjustment of HTP HPA axis (Pan et al., 2007). 
Chrystactinia mexicana 
C. mexicana is widely used in North America, Mexico, 
and some South American countries to treat diseases. 
According to Mexican traditional medicine, C. mexicana 
is used to treat fever and rheumatism and as diuretic, 
sexual enhancer, anticonvulsant, stimulant, and tonic 
(Cassani et al., 2015). Cassani et al investigated the 
antidepressant effects of aqueous C. mexicana  extract in 
mice using forced swim test and tail suspension test, 
and found this extract's antidepressant effects to be  
similar to those of a conventional antidepressant, 
clomipramine (Cassani et al., 2015). 
The main compounds detected in aqueous C. mexicana 
extract are apigenin (Figure 1), caffeic acid, fruolic acid, 
and coumaric acid. The observed antidepressant effects 
for C. mexicana can be due to phenylpropanoids 
including caffeic acid, coumaric acid and fruolic acid 
(Cassani et al., 2015). The antidepressant effects of 
fruolic acid and caffeic acid have already been 
demonstrated (Zeni et al., 2012). Fruolic acid has anti-
oxidant and anti-inflammatory effects and appears to 
be effective in treating neurodegenerative diseases (An 
et al., 2015). 
Fruolic acid acts as NMDA receptor antagonist and 
protects nerve cells against NMDA excitotoxic effects 
(Yu et al., 2006). In addition, fruolic acid affects nerve 
cell cycle and causes an increase in neural stem cell 
division in vivo and in vitro (Yabe et al., 2010). Apigenin 
is a flavonoid compound that is found in most plants 
with sedative, anti-anxiety, and antidepressant 
properties. In vivo antidepressant effects of C. mexicana 
have been demonstrated. Apigenin exerts pharmaco-
logical effects by binding to the benzodiazepine binding 
site in GABAA receptors (Avallone et al., 2000). 
The aerial parts of C. mexicana were air-dried and finely 
ground; afterward, aqueous extract was prepared at a 
ratio of 10 g of vegetal material per 90 mL of boiling 
distilled water and heated over 10 min. The resulting 
extract was allowed to cool at room temperature, 
filtered, and dried in a freezer dryer Telstar, at –50ºC 
and 0.01 mBar, yielding 17.6% (1.76 g) of dried aqueous 
extract. 
Chamaemelun nobile 
C. nobile, chamomile in English language and Babouneh 
in Persian language, is from Asteraceae/Compositae 
family. This plant is native to different Mediterranean 
regions but now-a-days, exhibits a wide pattern of 
distribution in Europe and temperate areas of Asia and 
even the Americas. Diuretic, perspiratory, gastrotonic, 
carminative, stomachic, digestive, anti-inflammatory, 
antispasmodic, soothing, and antibacterial properties 
have already been reported for C. nobile (Jäger and 
Saaby, 2011). An experimental study demonstrated 
antidepressant effects of C. nobile extract on 
progesterone-induced major depressive disorder.  
Although C. nobile extract decreased postpartum depre-
ssion indices significantly in rats, it exerted no effect on 
oxidative stress indices. C. nobile antidepressant effects 
Figure 1: Chemical structure of icarine, apigenin, magnolol and honokiol 
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 can be related to the compounds of this plant (Harati et 
al., 2014). Certain flavonoids such as apigenin, quer-
cetin, luteolin, and a terpenoid called ǂ-bisabolol are 
the main active chemical elements found in C. nobile. 
Apigenin, found in C. nobile, serves as a ligand for 
benzodiazepine receptor and hence has anti-anxiety 
and sedative properties, and significantly decreases 
delay in falling asleep. In contrast to diazepam, 
apigenin caused no impairment of memory (Jserves as a 
ligand). Another main compound of C. nobileis, 
quercetin which has been reported to induce inhibition 
of monoamine oxidase and hence sedative effects 
(Saaby et al., 2009). 
Magnolia officinalis 
Magnolia officinalis, M. dealbata, M. obovata, and M. 
grandiflora are the plants from family Magnoliacea 
which are used to treat neurological diseases such as 
convulsion, seizure, depression, and anxiety and as 
sedative and painkiller (Xu et al., 2008; Chen et al., 
2011). These plants are the main constituents of the 
herbal drugs used in Japan and China such as Banxia-
houpu and Saiboku-to (Nakazawa et al., 2003). 
Magnolol and honokiol (Figure 1) are two main com-
pounds identified in these plants. These compounds 
have been reported to cause antidepressant effects 
through affecting serotonergic system (Kuribara et al., 
1998).  Xu et al (2008) investigated the effect of the oral 
use of these two compounds on mild chronic stress-
induced depression. Mild chronic stress caused 
decrease in 5-HT and its metabolite, 5-HIAA, in 
different regions of the brain and suppressed the 
activity of platelets adenylyl cyclase. Serum cortices-
terone decreased due to chronic stress-induced 
depression, as well. Oral use of magnolol and honokiol 
(20 and 40 mg/kg) caused a decrease in duration of 
immobility in forced swim test and increased sucrose 
preference. 
These two compounds caused the changed amounts of 
5-HT, 5-HIAA, corticosterone, and adenylyl cyclase to 
return to baseline levels. The antidepressant effects of 
magnolol and honokiol in this study were attributed to 
the repair of the induced disturbance in serotonergic 
system, HPA axis, and AC-cAMP pathway (Xu et al., 
2008). 
Hypericum perforatum  
H. perforatum, St John's wort in English language, is 
native to Europe but exhibits spontaneous distribution 
across the world particularly in temperate and 
subtropical regions including China, Turkey, Ukraine, 
Russia, India, Canada and the USA (Butterweck and 
Schmidt, 2007). To date, several studies have been 
conducted on antidepressant effects of H. perforatum in 
mice and humans that confirmed the potential thera-
peutic effects of this plant (Butterweck and Schmidt, 
2007; Carpenter et al., 2008; Linde et al., 2008). H. 
perforatum extract contributes to not only treating 
depression but also preventing its recurrence. H. 
perforatum has a longer duration of response than 
citalopram (Singer et al., 2011). 
In the recent years, H. perforatum has been competing 
for being commercially available as an antidepressant 
and for this reason several studies have been conducted 
to detect the chemical compounds responsible for this 
effect and their action mechanisms (Butterweck, 2003). 
Biochemical investigations have demonstrated that H. 
perforatum is a weak inhibitor of monoamine oxidase 
but inhibits synaptosomal resorption of serotonin, 
dopamine, and norepinephrine. H. perforatum extract 
exerts down-regulatory effect on beta-adrenergic 
receptors and up-regulatory effect on serotonin recep-
tors, and changes the neurotransmitters concentrations 
in certain regions of the brain (Butterweck, 2003). 
Moreover, methanolic H. perforatum extract causes 
expression of HPA axis-controlling genes (Butterweck 
et al., 2001). A study showed that 150-75 mg/kg of H. 
perforatum extract improved chronic stress-induced 
depression symptoms and decreased the escalated 
levels of serum ACTH and corticosterone (Grundmann 
et al., 2010). This extract also caused reinforcement of 
anti-oxidant defense system and decline in two 
inflammatory factors, IL-6 and TNF-ǂ. 
H. perforatum antidepressant effect was attributed to 
anti-oxidant, anti-inflammatory, and endocrine system-
regulatory effects of this plant (Grundmann et al., 2010). 
The antidepressant effects of H. perforatum certain 
compounds such as hypericin, hyperforin, and 
isoquercetin have been demonstrated (Butterweck, 
2003). Injection with hypericin caused CRH and 
expression of its related mRNA to decrease in mice with 
depression (Butterweck,  2003). 
The aboveground parts (leaves, flowers and stem) were 
dried before extraction with 80% ethanol (vol/vol). The 
herb-to-extract ratio is 12:1 for a 100% native extract.  
Lavandula officinalis 
Lavandula genus, from family Lamiaceae, has 39 
various species and exhibits a global distribution. 
Lavandula has certain properties such as gastrotonic, 
diuretic, perspiratory, anticonvulsant, carminative, anti-
headache, nerve tonic, sedative, insomnia-treating, anti-
anxiety, and anti-Alzheimer's disease (Harati et al., 
2014). Antidepressant effects of a number of Lavandula 
species have been investigated. Hydroalcoholic and 
aqueous L. officinalis extracts (100-400 mg/kg), as with 
fluoxetine, exerted antidepressant effects in mice and 
significantly decreased immobility duration in forced 
swim test and tail suspension test (Harati et al., 2014). 
Inhaled L. officinalis extract caused an increase in 
plasma levels of serotonin and its metabolites in 
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 pregnant women at delivery (Mirzaei et al., 2009). 
In a single-blind, controlled, random clinical trial, daily 
bathing with L. angustifolia essential oil caused 
improvement of mood and a significant decrease in 
depression symptoms (Akhondzadeh et al., 2003). 
Antidepressant properties of linalool, the main 
compound of L. angustifolia essential oil and extract, 
have been demonstrated. A study used pretreatment 
with WAY100635 (receptor antagonist 5-HT1A), PCPA 
(serotonin synthesis inhibitor), yohimbine (receptor 
antagonist ǂ2), propranolol (receptor antagonist ǂǃ), 
and DSP-4 (noradrenergic neurotoxin) to investigate 
linalool effect on serotonergic and noradrenergic 
systems in mice. In addition, injection with SCH23390 
dopaminergic antagonist was used to investigate 
linalool effect on dopaminergic system in the mice.  
Pretreatment with WAY100635 and yohimbine inhibi-
ted the antidepressant effects of linalool but other 
compounds had no effects on linalool antidepressant 
activity (Guzmán-Gutiérrez, 2015). Linalool's antidepre-
ssant effects can be exerted through receptors of 
serotonergic and noradrenergic systems. 
Stems and flowers of L. officinalis were successively 
extracted with methanol by maceration at room tempe-
rature (25°C) over a period of 48 hours. 500 g of plant 
material and one liter of methanol were used in the 
extraction. Methanol containing the extract was then 
filtered through Whatman paper and the solvent was 
vacuum distilled at 65°C in a rotary evaporator. The 
remaining extract was finally dried in the oven at 30°C 
for two hours to ensure the removal of any residual 
solvent (lyophilisation). 
Salvia sclarea  
Salvia is considered the most important genus from 
family Lamiaceae. Antidepressant effects of a number 
of the species from this genus have been confirmed. An 
experimental study showed that antidepressant effect 
of S. sclarea was more marked than those of Rosmarinus 
officinalis, L. angustifolia, and Anthemis nobilis. To 
determine antidepressant actions mechanisms of S. 
sclarea, pretreatment with antagonist or agonist 
receptors of serotonin, dopamine, adrenaline, and 
GABA was used. The antidepressant effect of S. sclarea 
was inhibited by buspirone (serotonin antagonist), SCH
-23390 (aD1 receptor antagonist), and haloperidol 
(antagonist receptors D2, D3 and D4 or dopamine 
receptor)  
Therefore, it can be argued that antidepressant effect of 
S. sclarea is exerted through the dopaminergic system 
(Seol et al., 2010). Another study demonstrated that 
injection with hydroalcoholic extract of S. elegans 
caused relief of depression and anxiety in mice (Herrera
-Ruiz et al., 2006). Antidepressant effects of a number of 
chemical compounds found in the plants from salvia 
genus, such as linalool and apigenin, have been 
confirmed (Avallone et al., 2000) 
The leaves and flowers of Salvia were extracted in 60% 
ethanol solution at 50°C for 2 hours. Afterward, the 
extract was filtered through a Wattman #1 paper and 
extracted once again (under the same conditions) with a 
new solvent. The obtained extracts were reunited and 
the solvent was evaporated to dryness with a rotary 
evaporator under reduced pressure (Seol et al., 2010). 
Rosmarinus officinalis L.  
R. officinalis is from family Labiatae and has numerous 
pharmacological effects including hepatoprotective, 
antibacterial, antiulcer, anticoagulant, diuretic, antidia-
betic, anti-oxidant, and anti-inflammatory (Machado et 
al., 2013). An experimental study showed that treatment 
with hydroalcoholic R. officinalis extract (100 mg/kg) 
significantly decreased immobility duration in forced 
swim test and suspension in mice. Pretreatment with p-
chlorophenylalanine (serotonin synthesis inhibitor), 
NAN-190 (receptor antagonist 5-HT1A), ketanserin 
(receptor antagonist 5-HT2A), mCPBG (antagonist 
receptor 5-HT3), prazosin (ǂ1 adrenoreceptor anta-
gonist), SCH23390 (D1 dopamine receptor antagonist), 
and sulpiride (D2 dopamine receptor antagonist) 
inhibited the antidepressant effects of R. officinalis 
extract. 
Pretreatment with yohimbine (ǂ2 adrenoreceptor anta-
gonist) had no contribution to the extract's antidepre-
ssant effects. Indeed, antidepressant effects of R. 
officinalis extract may be exerted through mono-
aminergic system (Machado et al., 2009).  
The effects of R. officinalis polyphenols, consisting of 
carnosic acid, rosmarinic acid, and luteolin, on 
depression and PC12 cells, as an in vitro neurological 
model, were studied in mice. Proteomic analysis of 
PC12 cells demonstrated that R. officinalis caused up-
regulation of tyrosine hydroxylase and pyruvate 
carboxylase (the genes involved in gabaergic, seroto-
nergic and dopaminergic systems). R. officinalis poly-
phenols also protected nerve cells against corticosterone
-induced toxicity (Sasaki et al., 2013). 
Another main compound of R. officinalis, ursolic acid, at 
0.1 mg/kg exerted an antidepressant effect in mice, that 
were reinforced in the presence of dopamine receptor 
agonists and inhibited in the presence of dopamine 
receptor antagonists (Machado et al., 2012). 
Dried aerial parts of R. officinalis (600 g), was submitted 
to maceration in ethanol (96%) during 15 days at room 
temperature (25 ± 2°C). Thereafter, the extract was 
filtered and then concentrated under reduced pressure 
(at approximately 60°). The maceration was repeated 
three times. After removing the solvent by 
liophylization, this procedure gave 61 g of a green solid 
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 and dry ethanolic crude extract (Machado et al., 2009). 
Schinus molle 
S. molle, from family Anacardiaceae, is native to South 
America but has been introduced to most tropical and 
subtropical regions across the world. This plant has 
been reported to exert certain pharmacological proper-
ties including anti-inflammatory, antitumor, antifungal, 
anticonvulsant, and analgesic (Machado et al., 2007). 
Injection with n-hexane S. molle extract (3-600 mg/kg) 
significantly decreased the immobility duration in tail 
suspension test in mice with an efficacy comparable to 
that of fluoxetine (10 mg/kg).  
Pretreatment with p-chlorophenylalanine methyl ester 
(serotonin synthesis inhibitor), NAN-190 (5-HT1A 
receptor antagonist), WAY100635 (5-HT1A receptor 
antagonist of choice), prazosin (ǂ1 adrenoreceptor 
antagonist), ketanserin (5-HT2A/2C receptor antagonist 
of choice), MDL72222 (5-HT3 receptor antagonist of 
choice), yohimbine (ǂ2 adrenoreceptor antagonist), 
SCH23390 (D1 dopamine receptor antagonist), and 
sulpiride (D2 dopamine receptor antagonist) inhibited 
S. molle-induced antidepressant effects. Antidepressant 
effects of n-hexane S. molle extract can be exerted 
through serotonergic, dopaminergic and noradrenergic 
systems.  
Rutin, a flavonoid compound isolated from S. molle, at 
0.3-3 mg/kg concentrations exerted an antidepressant 
effect in mice, which was inhibited in the presence of p-
chlorophenylalanine methyl ester (serotonin synthesis 
inhibitor) and ǂ-methyl-p-tyrosine (noradrenaline 
synthesis inhibitor). Rutin induces antidepressant 
effects probably through increasing noradrenaline and 
serotonin in the synaptic gap (Machado et al., 2008). 
Dried sample was extracted with n-hexane at room 
temperature (25 ± 2°C) for 15 days. Thereafter, the 
extract was filtered and then concentrated under redu-
ced pressure (at approximately 60°). The maceration 
was repeated three times. The evaporation of solvent 
yielded a residue of 17.8 g of dried extract (4.6% w/w 
yield). The remaining residue was kept in a refrigerator 
and dissolved in saline with 10% Tween 80 before the 
behavioral tests (Machado et al., 2008). 
 
Discussion 
A variety of chemical and synthetic drugs are available 
to treat depression, but most of the patients fail to 
tolerate the adverse effects due to these drugs. 
Moreover, only 50% of the patients experience a 
complete recovery. Currently, studies are being 
increasingly conducted to detect new and economical 
drugs to treat depression with no adverse effects (Saki 
et al., 2014). Meanwhile, medicinal plants have been 
reported to exert pharmacologically optimal effects in 
treating depression in different animal models (Herrera
-Ruiz, Garccinal plants have been). Forced swim test 
and tail suspension test are animal pharmacological 
models commonly used to investigate antidepressant 
effects of chemical compounds and different plants in 
rodents (mostly mice). In addition to the above-
mentioned plants, certain plants such as Apocynum 
venetum, Zingiber officinale Roscoe, Tagetes lucida Cav, 
Eugenia brasiliensis Lam, Hedyosmum brasiliense, Crocus 
sativus, Bupleurum Falcaria, Scrophularia striata, Panax 
notoginseng, and Piper methysticum have been reported 
to exert antidepressant effects (Lehmann et al., 1996; 
Butterweck et al., 2001; Akhondzadeh et al., 2005; 
Guadarrama-Cruz et al., 2008; Kwon et al., 2010; 
Tolardo et al., 2010; Babri et al., 2012; Colla et al., 2012; 
Yao et al., 2012; Farzin et al., 2013). 
In the light of the above-mentioned, most of the medici-
nal plants and their active compounds reported in this 
review article were found to exert therapeutic effects 
through interactions with serotonergic (5-5HT3, 5-
5HT2A, and 5HT1A), noradrenergic (ǂ1 and ǂ2 receptors), 
and dopaminergic (D1 and D2 receptors) systems. In 
addition, medicinal plants cause regulation of HPA axis 
activity and decrease in the increased amounts of 
corticotropin, CRH, ACTH and CRH.  
Oxidative stress is one of the factors involved in 
depression pathophysiology, and different degrees of 
oxidative stress and a decrease in anti-oxidant enzymes 
have been reported in people with depression (Pandey 
et al., 1992). Evidence indicates that the levels of certain 
inflammatory mediators are higher in people with 
depression than other people (Liu et al., 2015). Some 
medicinal plants such as Danggui-Shaoyao-San and E. 
brevicornum exert antidepressant effects through 
reducing oxidative stress and inflammatory mediators 
(Zheng et al., 2010; Liu et al., 2015). 
A review of the findings on medicinal plants' 
antidepressant effects indicates that most research has 
been conducted on animal models and few plants 
including H. perforatum and L. officinalis have been 
investigated for antidepressant effects in humans. 
Given that the chemical compounds of the plants are 
metabolized through enzymatic processes of the body 
and liver and for this reason their structure and actions 
are likely to vary, it is recommended to conduct clinical 
trials in addition to preclinical studies (Yao et al., 2012). 
In most studies on antidepressant effects of medicinal 
plants, their toxicity and the margin of safety between 
therapeutic and toxic effects were not investigated. 
Cassani et al study reported no mortality due to oral 
use of C. mexicana up to 5,000 mg/kg concentration in 
rats. The active concentration to treat depression was 
seven times larger than LD50, which confirms the safety 
of this concentration. The body's weight and organs' 
relative weights are among the indices investigated in 
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 toxicological studies. These indices did not decrease 
due to the use of C. mexicana extract with no injuries or 
pathological variations in vital organs (Cassani et al., 
2015). Therefore, the toxic effects of medicinal plants 
and their active compounds are recommended to be 
studied to confirm the safety of use.   
Recently, promising evidence has been reported on the 
medicinal plants' effects in treating or preventing 
different diseases including impairments of memory 
(Baradaran et al., 2012; Rabiei et al., 2013; Alibabaei et 
al., 2014; Mokhtari-Dehkordi et al., 2014; Rabiei et al., 
2014; Rabiei et al., 2014; Rabiei et al., 2014; Rabiei and 
Rafieian, 2014; Rahnama et al., 2014) and different types 
of strokes (Rabiei et al., 2012; Rabiei et al., 2012; Rabiei 
et al., 2012; Rabiei et al., 2013; Rabiei and Rafieian-
Kopaei, 2014). Although these observations can be 
attributed to specific compounds of these plants, they 
have been attributed mainly to their anti-oxidant 
properties. 
In the recent years, selling nature-based compounds to 
treat depression and anxiety has been considerably on 
rising and these compounds have been welcome by 
consumers. In Europe, H. perforatum is used as capsule 
and tablet (300 mg, taken twice a day) to treat 
depression, but the US Food and Drug Administration 
has not approved it to treat depression. 5-hydroxy-
tryptophan, largely found in squash, turnip, cabbage, 
potato, sunflower seeds, and seaweed, is commercially 
available to treat depression. 5-hydroxytryptophan is 
able to improve depression symptoms through increa-
sing serotonin. Besides that, antidepressant effects of 
saffron, L. officinalis, and P. methysticum have been 
confirmed in human subjects and are commercially 
available to treat depression. 
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